- Home
- EXLS vs OGN Comparison
EXLS vs OGN Comparison
Compare EXLS & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXLS
- OGN
- Stock Information
- Founded
- EXLS 1999
- OGN 1923
- Country
- EXLS United States
- OGN United States
- Employees
- EXLS N/A
- OGN N/A
- Industry
- EXLS Business Services
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- EXLS Consumer Discretionary
- OGN Health Care
- Exchange
- EXLS Nasdaq
- OGN Nasdaq
- Market Cap
- EXLS 5.8B
- OGN 4.9B
- IPO Year
- EXLS 2006
- OGN N/A
- Fundamental
- Price
- EXLS $38.68
- OGN $18.30
- Analyst Decision
- EXLS Strong Buy
- OGN Hold
- Analyst Count
- EXLS 6
- OGN 4
- Target Price
- EXLS $39.67
- OGN $21.50
- AVG Volume (30 Days)
- EXLS 948.5K
- OGN 1.9M
- Earning Date
- EXLS 10-24-2024
- OGN 10-31-2024
- Dividend Yield
- EXLS N/A
- OGN 6.10%
- EPS Growth
- EXLS 6.43
- OGN 31.36
- EPS
- EXLS 1.08
- OGN 3.88
- Revenue
- EXLS $1,709,902,000.00
- OGN $6,346,000,000.00
- Revenue This Year
- EXLS $13.88
- OGN $2.91
- Revenue Next Year
- EXLS $11.85
- OGN $0.96
- P/E Ratio
- EXLS $36.13
- OGN $4.73
- Revenue Growth
- EXLS 10.91
- OGN 2.89
- 52 Week Low
- EXLS $25.17
- OGN $10.84
- 52 Week High
- EXLS $39.51
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- EXLS 78.13
- OGN 30.29
- Support Level
- EXLS $37.53
- OGN $18.22
- Resistance Level
- EXLS $38.72
- OGN $19.41
- Average True Range (ATR)
- EXLS 0.68
- OGN 0.51
- MACD
- EXLS 0.19
- OGN -0.14
- Stochastic Oscillator
- EXLS 98.62
- OGN 2.92
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage company's deep expertise in analytics, AI, ML and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging, Analytics. The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.